These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35603526)

  • 21. Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival.
    Bekbolsynov D; Mierzejewska B; Borucka J; Liwski RS; Greenshields AL; Breidenbach J; Gehring B; Leonard-Murali S; Khuder SA; Rees M; Green RC; Stepkowski SM
    Front Immunol; 2020; 11():580752. PubMed ID: 33193383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.
    Kosmoliaptsis V; Gjorgjimajkoska O; Sharples LD; Chaudhry AN; Chatzizacharias N; Peacock S; Torpey N; Bolton EM; Taylor CJ; Bradley JA
    Kidney Int; 2014 Nov; 86(5):1039-48. PubMed ID: 24717292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of HLA compatibility in pediatric liver transplantation.
    Francavilla R; Hadzic N; Underhill J; Heaton N; Rela M; Mieli-Vergani G; Donaldson P
    Transplantation; 1998 Jul; 66(1):53-8. PubMed ID: 9679822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
    Rees MT; Darke C
    Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated human leukocyte antigen mismatches in lung re-transplantation.
    Sommer W; Hallensleben M; Ius F; Kühn C; Tudorache I; Avsar M; Salman J; Siemeni T; Greer M; Gottlieb J; Boethig D; Blasczyk R; Haverich A; Warnecke G
    Transpl Immunol; 2017 Feb; 40():1-7. PubMed ID: 27923603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of HLA class II incompatibility in living donor liver transplantation.
    Campos J; Quijano Y; Franco A; Eiras P; López-Santamaria M; Gámez M; Núño J; Murcia J; López P; Zarzosa G; Garcia M; Albillo A; Bárcena R; Castañer JL; Vicente E
    Transplant Proc; 2003 Aug; 35(5):1888-91. PubMed ID: 12962835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.
    Alves TA; Nascimento E; de Castro LB; Fabreti-Oliveira RA
    Transpl Immunol; 2023 Oct; 80():101908. PubMed ID: 37536379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HLA compatibility in pediatric living-related liver transplantation.
    Kasahara M; Kiuchi T; Uryuhara K; Uemoto S; Fujimoto Y; Ogura Y; Oike F; Kaihara S; Egawa H; Tanaka K
    Transplantation; 2002 Oct; 74(8):1175-80. PubMed ID: 12438966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
    Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
    Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
    Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
    Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
    Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.